These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
733 related articles for article (PubMed ID: 19370661)
21. Combination formoterol and budesonide as maintenance and reliever therapy versus inhaled steroid maintenance for chronic asthma in adults and children. Cates CJ; Lasserson TJ Cochrane Database Syst Rev; 2009 Apr; (2):CD007313. PubMed ID: 19370682 [TBL] [Abstract][Full Text] [Related]
22. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma. Ni Chroinin M; Greenstone IR; Danish A; Magdolinos H; Masse V; Zhang X; Ducharme FM Cochrane Database Syst Rev; 2005 Oct; (4):CD005535. PubMed ID: 16235410 [TBL] [Abstract][Full Text] [Related]
24. Formoterol versus short-acting beta-agonists as relief medication for adults and children with asthma. Welsh EJ; Cates CJ Cochrane Database Syst Rev; 2010 Sep; 2010(9):CD008418. PubMed ID: 20824877 [TBL] [Abstract][Full Text] [Related]
25. Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children. Lasserson TJ; Ferrara G; Casali L Cochrane Database Syst Rev; 2011 Dec; 2011(12):CD004106. PubMed ID: 22161385 [TBL] [Abstract][Full Text] [Related]
26. Combination formoterol and inhaled steroid versus beta2-agonist as relief medication for chronic asthma in adults and children. Cates CJ; Lasserson TJ Cochrane Database Syst Rev; 2009 Jan; 2009(1):CD007085. PubMed ID: 19160317 [TBL] [Abstract][Full Text] [Related]
27. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults. Ni CM; Greenstone IR; Ducharme FM Cochrane Database Syst Rev; 2005 Apr; (2):CD005307. PubMed ID: 15846751 [TBL] [Abstract][Full Text] [Related]
28. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma. Ducharme FM; Lasserson TJ; Cates CJ Cochrane Database Syst Rev; 2006 Oct; (4):CD003137. PubMed ID: 17054161 [TBL] [Abstract][Full Text] [Related]
29. Addition of long-acting beta-agonists to inhaled corticosteroids for chronic asthma in children. Ni Chroinin M; Lasserson TJ; Greenstone I; Ducharme FM Cochrane Database Syst Rev; 2009 Jul; (3):CD007949. PubMed ID: 19588447 [TBL] [Abstract][Full Text] [Related]
30. Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus the same dose of ICS alone for adults with asthma. Anderson DE; Kew KM; Boyter AC Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD011397. PubMed ID: 26301488 [TBL] [Abstract][Full Text] [Related]
31. Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma. Ducharme FM; Ni Chroinin M; Greenstone I; Lasserson TJ Cochrane Database Syst Rev; 2010 Apr; (4):CD005533. PubMed ID: 20393943 [TBL] [Abstract][Full Text] [Related]
32. The safety of formoterol among patients with asthma using inhaled corticosteroids. Systematic review and meta-analysis. Jaeschke R; O'Byrne PM; Nair P; Mejza F; Leśniak W; Brozek J; Thabane L; Cheng J; Bała M; Schünemann HJ; Sears MR; Guyatt G Pol Arch Med Wewn; 2008 Nov; 118(11):627-35. PubMed ID: 19140566 [TBL] [Abstract][Full Text] [Related]
33. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma. Greenstone IR; Ni Chroinin MN; Masse V; Danish A; Magdalinos H; Zhang X; Ducharme FM Cochrane Database Syst Rev; 2005 Oct; (4):CD005533. PubMed ID: 16235409 [TBL] [Abstract][Full Text] [Related]
34. Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults. Chauhan BF; Chartrand C; Ducharme FM Cochrane Database Syst Rev; 2012 Dec; 12():CD009611. PubMed ID: 23235678 [TBL] [Abstract][Full Text] [Related]
35. Inhaled magnesium sulfate in the treatment of acute asthma. Knightly R; Milan SJ; Hughes R; Knopp-Sihota JA; Rowe BH; Normansell R; Powell C Cochrane Database Syst Rev; 2017 Nov; 11(11):CD003898. PubMed ID: 29182799 [TBL] [Abstract][Full Text] [Related]
36. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol. Frois C; Wu EQ; Ray S; Colice GL Clin Ther; 2009 Dec; 31(12):2779-803. PubMed ID: 20110019 [TBL] [Abstract][Full Text] [Related]
37. Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults. Chauhan BF; Chartrand C; Ducharme FM Cochrane Database Syst Rev; 2013 Feb; (2):CD009611. PubMed ID: 23450606 [TBL] [Abstract][Full Text] [Related]
38. Stopping long-acting beta2-agonists (LABA) for adults with asthma well controlled by LABA and inhaled corticosteroids. Ahmad S; Kew KM; Normansell R Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD011306. PubMed ID: 26089258 [TBL] [Abstract][Full Text] [Related]
39. Long-acting beta-agonists: a review of formoterol safety data from asthma clinical trials. Sears MR; Ottosson A; Radner F; Suissa S Eur Respir J; 2009 Jan; 33(1):21-32. PubMed ID: 18768573 [TBL] [Abstract][Full Text] [Related]
40. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults and children. Ni Chroinin M; Greenstone I; Lasserson TJ; Ducharme FM Cochrane Database Syst Rev; 2009 Oct; 2009(4):CD005307. PubMed ID: 19821344 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]